Karin Vickberg
Biomedical Analyst at Department of Medical Sciences; Infection medicine
- E-mail:
- karin.vickberg@medsci.uu.se
- Visiting address:
- Akademiska sjukhuset
Infektion, ingång 34, 1 tr - Postal address:
- Akademiska sjukhuset
Infektion, ingång 34, 1 tr
751 85 Uppsala
Short presentation
I work as an infection biologist in the research group for antibiotic research. We are mainly investigating whether it is possible to combine different antibiotics in order to kill multi-drug resistant bacteria, which otherwise would be resistant to the antibiotics if they were given separately.
Publications
Recent publications
-
Part of Antimicrobial Agents and Chemotherapy, 2024
- DOI for Impact of porin deficiency on the synergistic potential of colistin in combination with β-lactam/β-lactamase inhibitors against ESBL- and carbapenemase-producing Klebsiella pneumoniae
- Download full text (pdf) of Impact of porin deficiency on the synergistic potential of colistin in combination with β-lactam/β-lactamase inhibitors against ESBL- and carbapenemase-producing Klebsiella pneumoniae
-
Part of Antibiotics, 2022
- DOI for Evaluation of In Vitro Activity of Double-Carbapenem Combinations against KPC-2-, OXA-48-and NDM-Producing Escherichia coli and Klebsiella pneumoniae
- Download full text (pdf) of Evaluation of In Vitro Activity of Double-Carbapenem Combinations against KPC-2-, OXA-48-and NDM-Producing Escherichia coli and Klebsiella pneumoniae
All publications
Articles in journal
-
Part of Antimicrobial Agents and Chemotherapy, 2024
- DOI for Impact of porin deficiency on the synergistic potential of colistin in combination with β-lactam/β-lactamase inhibitors against ESBL- and carbapenemase-producing Klebsiella pneumoniae
- Download full text (pdf) of Impact of porin deficiency on the synergistic potential of colistin in combination with β-lactam/β-lactamase inhibitors against ESBL- and carbapenemase-producing Klebsiella pneumoniae
-
Part of Antibiotics, 2022
- DOI for Evaluation of In Vitro Activity of Double-Carbapenem Combinations against KPC-2-, OXA-48-and NDM-Producing Escherichia coli and Klebsiella pneumoniae
- Download full text (pdf) of Evaluation of In Vitro Activity of Double-Carbapenem Combinations against KPC-2-, OXA-48-and NDM-Producing Escherichia coli and Klebsiella pneumoniae